Immatics (IMTX) Short-Term Debt repayments (2022 - 2025)

Immatics' (IMTX) quarterly Short-Term Debt repayments came in at -$870704.5 in Q4 2025, down 3.93% year-on-year from -$906324.2 in Q4 2024, and down 0.92% quarter-over-quarter from -$862762.7 in Q3 2025.

Immatics (IMTX) Short-Term Debt repayments (2022 - 2025) Analysis & Trends

Immatics has disclosed Short-Term Debt repayments across 4 years of filings, most recently posting -$870704.5 for Q4 2025.

  • Short-Term Debt repayments for Q4 2025 came in at -$870704.5, down 3.93% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.5 million (down 1549.35% YoY), and the FY2025 annual result was -$3.3 million, down 55.49% from the prior year.
  • Short-Term Debt repayments came in at -$870704.5 for Q4 2025 at Immatics, down from -$862762.7 in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $3.1 million in Q4 2023 to a low of -$1.1 million in Q3 2023.
  • The 4-year median for Short-Term Debt repayments is -$850270.7 (2024), against an average of -$542186.7.
  • Across the five-year window, Short-Term Debt repayments surged 544.93% in 2023 and tumbled 127.1% in 2024, its largest moves.
  • Immatics' Short-Term Debt repayments stood at -$694788.5 in 2022, then surged by 544.93% to $3.1 million in 2023, then tumbled by 127.1% to -$837778.8 in 2024, then fell by 3.93% to -$870704.5 in 2025.
  • The last three Short-Term Debt repayments figures came in at -$870704.5 (Q4 2025), -$862762.7 (Q3 2025), and -$837778.8 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt repayments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 102,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -482,347.21
10 Immatics 14.67 Bn 14.67 Bn - -870,704.55

Historic Data

Download Data
DateValue
Dec 31, 2025 -870,704.55
Dec 31, 2025 -870,704.55
Sep 30, 2025 -862,762.66
Sep 30, 2025 -862,762.66
Dec 31, 2024 -837,778.79
Dec 31, 2024 -837,778.79
Sep 30, 2024 -912,620.41
Sep 30, 2024 -912,620.41
Dec 31, 2023 3.09 Mn
Dec 31, 2023 3.09 Mn
Sep 30, 2023 -1.10 Mn
Sep 30, 2023 -1.10 Mn
Jun 30, 2023 -1.09 Mn
Jun 30, 2023 -1.09 Mn
Mar 31, 2023 -929,514.02
Mar 31, 2023 -929,514.02
Dec 31, 2022 -694,788.46
Dec 31, 2022 -694,788.46
Sep 30, 2022 -774,354.69
Sep 30, 2022 -774,354.69